ArticleRMD open2024

What benefit-risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment.

Rieke Alten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.